Small Intestinal Alterations in Severely Obese Hyperglycemic Subjects
- 1 February 2011
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (2) , E379-E383
Abstract
Context: Type 2 diabetes mellitus (DM2) is associated with small intestinal hyperplasia and hypertrophy in rodents. Moreover, the small intestine is increasingly acknowledged to play a role in the pathophysiology of DM2. Objective: The objective of the study was to investigate the relation between plasma markers of small intestinal function and chronic hyperglycemia in man. Design, Setting, and Participants: We conducted a cross-sectional observational study of 40 severely obese subjects with chronic hyperglycemia and 30 severely obese subjects without chronic hyperglycemia who were indicated for bariatric surgery. Main Outcome Measures: We assessed plasma levels of citrulline, representing small intestinal enterocyte mass, intestinal fatty acid binding protein (I-FABP), a marker of enterocyte loss, and glucagon-like peptide-2, an intestinotrophic factor, and related them to glycated hemoglobin (HbA1c) levels. Results: Plasma citrulline and I-FABP levels were both significantly elevated in subjects with chronic hyperglycemia (HbA1c > 6.0%) compared with subjects with a normal HbA1c (≤ 6.0%) (citrulline, 35 ± 2.1 μmvs. 26 ± 1.4 μm, P = 0.001; I-FABP, 140 ± 22 pg/ml vs. 69 ± 14 pg/ml, P = 0.001). Moreover, plasma citrulline and I-FABP levels correlated with HbA1c levels (citrulline, rs = 0.30, P = 0.02; I-FABP, rs = 0.33, P = 0.005). The I-FABP to citrulline ratio was higher in subjects with an elevated HbA1c (4.0 vs. 3.1, P = 0.03). Plasma glucagon-like peptide-2 levels were not related to citrulline or I-FABP levels (rs = 0.06, P = 0.67; rs 0.08, P = 0.54, respectively). Conclusion: Chronically elevated glucose levels in obese individuals are associated with increased small intestinal enterocyte mass and increased enterocyte loss. These findings argue for the further exploration of the role of the intestine in the pathophysiology of DM2.Keywords
This publication has 17 references indexed in Scilit:
- Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitusNature Reviews Endocrinology, 2010
- Global estimates of the prevalence of diabetes for 2010 and 2030Diabetes Research and Clinical Practice, 2010
- Intestinal hormones and growth factors: Effects on the small intestineWorld Journal of Gastroenterology, 2009
- Intestinal Gluconeogenesis Is a Key Factor for Early Metabolic Changes after Gastric Bypass but Not after Gastric Lap-Band in MiceCell Metabolism, 2008
- Citrulline as a biomarker of intestinal failure due to enterocyte mass reductionClinical Nutrition, 2008
- The role of gut hormones in glucose homeostasisJournal of Clinical Investigation, 2007
- Fatty acid-binding proteins as plasma markers of tissue injuryClinica Chimica Acta, 2005
- Morphological Changes and Increased Sucrase and Isomaltase Activity in Small Intestines of Insulin-Deficient and Type 2 Diabetic RatsEndocrine Journal, 2003
- Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic ratsMetabolism, 2001
- Human intestinal fatty acid binding protein: Report of an assay with studies in normal volunteers and intestinal ischemiaSurgery, 1997